A Deep Dive: Understanding the Neurological Toll of Long COVID

Ravindra Ganesh, MD, MBBS, FACP, Dip ABOM, Svetlana Blitshteyn, MD, FAAN, and Monica Verduzco-Gutierrez, MD, discuss Long COVID's prevalence—noting that 1 in 5 Americans and 1 in 10 patients post-COVID may be affected.

Contagion and NeurologyLive Present: Long COVID Roundtable
Latest Videos

Conference Coverage

View All
Global Action Against AMR
Global Action Against AMR

September 26th 2024

Addressing Antimicrobial Resistance in Women
Addressing Antimicrobial Resistance in Women

September 17th 2024

GARDP's Strategy for Addressing AMR: Spotlight on BWC0977
GARDP's Strategy for Addressing AMR: Spotlight on BWC0977

September 13th 2024

Differentiating Between DNA and mRNA Platforms
Differentiating Between DNA and mRNA Platforms

September 13th 2024

Video Series

Latest News

© 2024 MJH Life Sciences

All rights reserved.